PCRX · trading date Oct 9, 2026 · previous close $36.40 · source: Alpaca (IEX feed, not consolidated full-market data).
Key Financials
Revenue
$726.41M
Net income
$7.03M
Total assets
$1.26B
Total liabilities
$571.81M
Stockholders' equity
$693.11M
Cash & equivalents
$158.55M
Operating income
$19.19M
Operating cash flow
$151.99M
Capital expenditures
$15.33M
Fiscal year 2025, via 10-K filed 2026-02-26.
A dash means this figure wasn't reported in the source filing under a field State Ledger recognizes - not that the value is zero.
Financial Performance
Operating margin
2.6%
Net margin
1.0%
Free cash flow
$136.66M
Free cash flow margin
18.8%
Liabilities / assets
45.2%
Equity / assets
54.8%
CapEx / revenue
2.1%
Operating cash flow / net income
21.61×
Derived from the fiscal year 2025 figures above. These metrics are mathematical calculations and do not represent a rating or assessment of the company.
"Most recent SEC filing" may differ from the filing used for the financial figures above.
Location
Brisbane, CA 94005
2000 SIERRA POINT PARKWAY
Data & Methodology
SEC EDGAR submissions API (identity, collected Sep 19, 2026, 15:11 UTC) and SEC XBRL Company Facts API (financials, collected Sep 26, 2026, 15:16 UTC) · figures as originally filed, not restated · a dash always means a value wasn't reported, never a real zero.